Gene · 1828
Papers3,287
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,287
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Skin barrier function in children with eosinophilic esophagitis. | J Allergy Clin Immunol Glob | 2026 | 41777453 | PubTator, text mining | PubMed |
| Proteolytic dysregulation in the skin: insight from rare monogenic skin diseases. | Cell Tissue Res | 2026 | 41776113 | PubTator, text mining | PubMed |
| Differentially expressed proteins in plasma-derived extracellular vesicles from chronic myeloid leukemia patients. | Front Genet | 2026 | 41773228 | PubTator, text mining | PubMed |
| Proton pump inhibitors modulate esophageal epithelial barrier function and crosstalk with eosinophils. | Pediatr Allergy Immunol | 2026 | 41760554 | PubTator, text mining | PubMed |
| FOXC1 Regulates Cytokine Signaling, Inflammatory Pathways, and Retinoid Metabolism to Maintain Limbal Epithelial Cell Homeostasis In Vitro. | Int J Mol Sci | 2026 | 41752009 | PubTator, text mining | PubMed |
| Case Report: Pemphigus following COVID-19 mRNA vaccination: two cases achieving long-term remission without relapse. | Front Immunol | 2026 | 41743705 | PubTator, text mining | PubMed |
| Intratumoral bacterium Enterocloster bolteae promotes hepatocellular carcinoma progression by directly binding tumor cells. | Cell Host Microbe | 2026 | 41742409 | PubTator, text mining | PubMed |
| Nomogram for predicting risk of relapse following complete remission in pemphigus patients. | J Dermatolog Treat | 2026 | 41741398 | PubTator, text mining | PubMed |
| Dentofacial Malocclusion and Salivary Biomarkers in Asthmatic Patients: A Scoping Review. | Int Dent J | 2026 | 41740246 | PubTator, text mining | PubMed |
| A case of juvenile pemphigus vulgaris effectively treated with dupilumab. | JAAD Case Rep | 2026 | 41728065 | PubTator, text mining | PubMed |
| From basic biology to engineered therapies: the keratinocyte stem cell playbook. | Front Med Technol | 2026 | 41726153 | PubTator, text mining | PubMed |
| Proteomic Insights into Venous Thromboembolism. | Med Sci (Basel) | 2026 | 41718141 | PubTator, text mining | PubMed |
| Caspase-activation powers anti-Desmoglein 3-induced acantholysis in human epidermis. | Cell Death Discov | 2026 | 41714593 | PubTator, text mining | PubMed |
| Comprehensive Serum Proteomics Uncovers Epigenetic and Inflammatory Pathways Underlying Primary Open-Angle Glaucoma. | J Proteome Res | 2026 | 41679738 | PubTator, text mining | PubMed |
| Correlation of platelet-related parameters and autoantibodies in patients with autoimmune bullous diseases. | Lab Med | 2026 | 41672569 | PubTator, text mining | PubMed |
| Anti-Desmoglein 3 Avidity Correlates Better With Pemphigus Vulgaris Severity Than Anti-Desmoglein 3 Concentration. | Int J Dermatol | 2026 | 41670289 | PubTator, text mining | PubMed |
| Pemphigus Foliaceus Mimicking Erythema Annulare Centrifugum: A Case Report. | Cureus | 2026 | 41646576 | PubTator, text mining | PubMed |
| Oral lichenoid lesions in association with immunotherapies: a report of two cases and a review of published work. | BMC Oral Health | 2026 | 41593588 | PubTator, text mining | PubMed |
| Clinical Phenotype Transition in Pemphigus May Suggest Undertreatment with Rituximab: Findings from a Retrospective Single-Centre Analysis of Relapsed Patients. | Dermatology | 2026 | 41553945 | PubTator, text mining | PubMed |
| Comparing the genetic and serum expression of LL-37 Antimicrobial Peptide in pemphigus vulgaris and pemphigus foliaceus patients. | An Bras Dermatol | 2026 | 41544316 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1828/papers?page=3